Liverpool biocampus mulls LABV

10 April 2012 The Royal Liverpool and Broadgreen University Hospitals Trust (RLBUHT) is considering using a local asset-backed vehicle (LABV) approach to build a new 28m life science and innovation centre.
On behalf of the University of Liverpool and Liverpool City Council, the Trust is seeking to market test private contractors to see how Liverpool's new Bio Innovation Centre - the the first phase of the delivery of an international life science bio-campus - could be financed and built. 

The authority is looking for feedback on whether to procure the building using Procure 21+, a restricted negotiated procedure or a local asset-backed vehicle company.

The deal will involve the construction of a new innovation centre "to connect academics, industry professionals, investors, clinicians and the NHS", according to a statement. The centre will be built on a 10 hectare site in the ownership of RLBUHT, with full planning permission for commercial and research development.

The institutions' key objective is for the new campus to place Liverpool alongside Boston and Singapore as a leading international centre for the life sciences. Procurement works are hoped to begin by the end of 2012 with the centre being in full operation by May 2014.

This page was last updated on:
18 August 2017.

thumb

Time to be bold

PF2 projects are slowly bubbling to the surface, but will the market take the bait?

thumb

The Insurance Man

Darryl Murphy, head of debt investment at Aviva Investors discusses where he intends to take the organisation next

register

Register now to get un-restricted access to all sections of the website.

Want to see more first? Try our free preview...